Literature DB >> 23457675

Quantitative sputum cell counts to monitor bronchitis: a qualitative study of physician and patient perspectives.

Liesel D'silva1, Helen Neighbour, Amiram Gafni, Katherine Radford, Freddy Hargreave, Parameswaran Nair.   

Abstract

Many common diseases affecting the airways are characterized by airway inflammation. The measurement of this inflammation has a significant role in the management of these diseases. Quantitative sputum cell counts provide a measurement of the type and severity of inflammation present. Sputum cell counts are used in routine clinical practice in some centres but their use is not widespread. The present study used a standardized questionnaire to determine both patients' and physicians' attitudes toward the use of sputum cell counts. The use of sputum cell counts was well accepted by patients and physicians. Ninety per cent of patients were satisfied with the test. Sixty per cent of family physicians were satisfied with the test and 80% were in favour of it being funded by the government. The authors recommend more widespread use of sputum cell counts to guide the management of airway diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23457675      PMCID: PMC3628647          DOI: 10.1155/2013/248167

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  24 in total

1.  The effects of cash and lottery incentives on mailed surveys to physicians: a randomized trial.

Authors:  Gabriel M Leung; Lai Ming Ho; Moon Fai Chan; Janice M M Johnston; Fung Kam Wong
Journal:  J Clin Epidemiol       Date:  2002-08       Impact factor: 6.437

Review 2.  Asthma, COPD and bronchitis are just components of airway disease.

Authors:  F E Hargreave; K Parameswaran
Journal:  Eur Respir J       Date:  2006-08       Impact factor: 16.671

Review 3.  Clinical applications of induced sputum.

Authors:  Christopher E Brightling
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

Review 4.  Quantitative sputum cell counts as a marker of airway inflammation in clinical practice.

Authors:  Frederick E Hargreave
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-02

Review 5.  Pharmacological management of mild or moderate persistent asthma.

Authors:  Paul M O'Byrne; Krishnan Parameswaran
Journal:  Lancet       Date:  2006-08-26       Impact factor: 79.321

Review 6.  Exhaled nitric oxide measurements: clinical application and interpretation.

Authors:  D R Taylor; M W Pijnenburg; A D Smith; J C De Jongste
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

7.  Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations.

Authors:  L Jayaram; M M Pizzichini; R J Cook; L-P Boulet; C Lemière; E Pizzichini; A Cartier; P Hussack; C H Goldsmith; M Laviolette; K Parameswaran; F E Hargreave
Journal:  Eur Respir J       Date:  2006-03       Impact factor: 16.671

Review 8.  Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines.

Authors:  Christopher E Brightling
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

9.  The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial.

Authors:  Dominick E Shaw; Mike A Berry; Mike Thomas; Ruth H Green; Chris E Brightling; Andrew J Wardlaw; Ian D Pavord
Journal:  Am J Respir Crit Care Med       Date:  2007-05-11       Impact factor: 21.405

10.  Key barriers to optimal management of adult asthma in Australia: physician and patient perspectives.

Authors:  Maurice McDonald Heiner
Journal:  Curr Med Res Opin       Date:  2007-08       Impact factor: 2.580

View more
  4 in total

Review 1.  Update on clinical inflammometry for the management of airway diseases.

Authors:  Parameswaran Nair
Journal:  Can Respir J       Date:  2013 Mar-Apr       Impact factor: 2.409

2.  Sputum cell counts to manage prednisone-dependent asthma: effects on FEV1 and eosinophilic exacerbations.

Authors:  Afia Aziz-Ur-Rehman; Angira Dasgupta; Melanie Kjarsgaard; Frederick E Hargreave; Parameswaran Nair
Journal:  Allergy Asthma Clin Immunol       Date:  2017-04-04       Impact factor: 3.406

3.  Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia.

Authors:  P Nair; S I Ochkur; C Protheroe; K Radford; A Efthimiadis; N A Lee; J J Lee
Journal:  Allergy       Date:  2013-08-09       Impact factor: 13.146

Review 4.  Asthma Endotypes and an Overview of Targeted Therapy for Asthma.

Authors:  Sarah Svenningsen; Parameswaran Nair
Journal:  Front Med (Lausanne)       Date:  2017-09-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.